Description
| Strength | 40 mg |
| Brand Name | LMWX |
| Manufacturer | Abbott |
| Packaging Type | Box |
| Usage/Application | To Manage Blood Clot Formation In The Body. |
| Shelf Life | 24 Months |
| Composition | Enoxaparin Sodium |
| Form | Injection |
Product’s Details:
- LMWX 40 mg (Enoxaparin Sodium Injection) is an anticoagulant belonging to the low molecular weight heparin (LMWH) class. It works by inhibiting Factor Xa and thrombin, thereby preventing the formation and extension of blood clots. With a longer half-life and more predictable pharmacokinetics than unfractionated heparin, it is widely used in the prevention and management of thromboembolic disorders.
- Composition: Each prefilled syringe contains 40 mg (0.4 ml) of Enoxaparin Sodium in sterile solution for subcutaneous injection.
- Features & Benefits:
- Prevents and treats harmful blood clot formation/li>
- Inhibits Factor Xa and thrombin for effective anticoagulation
- Longer half-life and predictable action compared to unfractionated heparin
- Convenient prefilled syringe for ease of administration
- Clinically proven safety and efficacy
- Side Effects: Common side effects may include:
- Mild bleeding or bruising at injection site
- Headache
- Nausea
- Low-grade fever
- Skin irritation or rash
Severe (rare) side effects:
- Severe bleeding
- Allergic reactions (e.g., difficulty breathing, swelling)
- Low platelet count (thrombocytopenia)
- Spinal/epidural hematoma in high-risk cases
- Storage:
- Store at 15°C to 25°C
- Protect from light and moisture
- Do not freeze
- Do not massage the injection site after administration
- Rotate injection sites to reduce bruising
- Follow the exact dosing schedule as prescribed
Reviews
There are no reviews yet.